Skip to main content
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.950
+0.270 (5.77%)
At close: Oct 4, 2024, 4:00 PM
4.940
-0.010 (-0.20%)
After-hours: Oct 4, 2024, 7:16 PM EDT

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $20.10M in the quarter ending June 30, 2024, with 51.79% growth. This brings the company's revenue in the last twelve months to $58.36M, up 25.45% year-over-year. In the year 2023, Aquestive Therapeutics had annual revenue of $50.58M with 6.09% growth.

Revenue (ttm)
$58.36M
Revenue Growth
+25.45%
P/S Ratio
6.29
Revenue / Employee
$432,296
Employees
135
Market Cap
450.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.58M2.90M6.09%
Dec 31, 202247.68M-3.15M-6.20%
Dec 31, 202150.83M4.98M10.87%
Dec 31, 202045.85M-6.76M-12.85%
Dec 31, 201952.61M-14.82M-21.98%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonida Senior Living 244.78M
Ginkgo Bioworks Holdings 184.34M
Xeris Biopharma Holdings 181.41M
Valneva SE 167.66M
Quanterix 129.33M
Alector 55.28M
EyePoint Pharmaceuticals 50.39M
Absci 3.25M
Revenue Rankings

AQST News

More News